People with hidradenitis suppurativa (HS) have described hiding the condition both visually and verbally, worrying about exposure, and missing social activities or important life events. Some also report feeling misunderstood during healthcare encounters. A small observational study separately found associations between stigmatization, painful lesions, disrupted socializing, and mental-health measures. These findings describe experiences and relationships in research, not what every person with HS feels. For readers in Massachusetts, they offer context for understanding emotional strain without establishing local prevalence, a diagnosis, or a particular treatment need.
Concealment can involve both visibility and conversation
A systematic review synthesizing qualitative accounts of life with HS identified a theme the authors called “A stigmatized identity: concealed and revealed.” People described trying to conceal HS visually and verbally, alongside anticipation and fear of exposure. The burden was therefore not limited to whether another person actually noticed the condition.
Three distinctions help explain these accounts without assuming everyone experiences them:
- Visual concealment: trying to keep the condition from being seen.
- Verbal concealment: keeping the condition out of conversations or not discussing it.
- Anticipated exposure: worrying that something being kept private may become known.
Anticipating exposure is different from reporting an actual rejection. Both matter when interpreting stigma, but they are not interchangeable. Similarly, choosing privacy does not, by itself, establish that someone feels ashamed. The review describes experiences within the included research, not a rule about how people should disclose a physical condition.
Pain, stigma, and social participation are related but distinct
The qualitative review also identified “Putting the brakes on life.” Physical, psychological, and social consequences of HS were described as contributing to missed life events. The authors noted that these missed experiences could accumulate and influence the course of someone's life. That is broader than a single canceled activity, but it does not mean every person experiences the same disruption.
It is important not to attribute every limitation to embarrassment. Physical pain, concern about exposure, and difficult social experiences are different parts of the evidence. Collapsing them into one explanation can overlook what a person is actually describing.
| Experience | Evidence reported | Important distinction |
|---|---|---|
| Concealment | Qualitative accounts describe hiding HS and fearing exposure. | Anticipated exposure does not establish actual rejection. |
| Missed life events | The synthesis describes physical, psychological, and social consequences. | Disrupted participation is not explained by stigma alone. |
| Pain and socializing | The observational study found associations with stigmatization. | An association does not establish which factor caused another. |
These distinctions leave room for individual differences. Someone's account of pain should not automatically be reinterpreted as anxiety, and a concern about being exposed should not be dismissed simply because no rejection has occurred.
What the two research designs can establish
The observational study of stigmatization in adults with HS included 63 participants, consisting of 29 male and 34 female patients aged 18 to 66. Researchers used a questionnaire and measures covering quality of life, depression, social anxiety, body image, stigmatization, and disease severity.
Higher stigmatization scores correlated with higher depression and social anxiety scores, poorer quality of life, and worse body-image perception. Stigmatization was also associated with painful lesions and disruption of socializing. Disease severity and reporting being psychologically negatively affected by HS were the study's main statistical predictors of stigmatization.
The study was cross-sectional, a limitation explicitly acknowledged in its abstract. These relationships do not establish whether stigma caused emotional difficulties, emotional difficulties influenced stigma scores, or other factors contributed. “Predictor” here describes a statistical relationship within the study, not a forecast of an individual's future.
The qualitative synthesis answers a different question: how people describe living with HS. It included 14 studies with varying methodological quality. Four fulfilled most quality criteria, eight fulfilled some, and two fulfilled few. Its themes organize reported experiences; they are not percentages showing how frequently each experience occurs. Neither source establishes Massachusetts prevalence or supports diagnosing a reader from a description that feels familiar.
Difficult healthcare encounters can add another burden
“Falling through the cracks” was the qualitative review's third theme. Participants reported delayed diagnosis, misdiagnosis, and difficulty accessing care. They also described feeling unheard or misunderstood by healthcare professionals, with some healthcare interactions enhancing shame.
These accounts identify distinct problems rather than a single negative feeling about healthcare:
- Recognition: reports of delayed diagnosis or misdiagnosis concerned whether the condition was identified.
- Access: reports of difficulty obtaining care concerned reaching services.
- Interaction: feeling unheard or misunderstood concerned the experience of being received and understood.
Acknowledging these experiences does not imply that every encounter is dismissive. It does help explain why emotional distress cannot always be understood solely as a reaction to physical symptoms. The care experience itself was part of what participants described.
The same synthesis reported that social support and psychological acceptance helped people cope. Connecting with others who had HS might have a particular role in preserving a positive self-identity. These are reported supports, not proof that a specific group, therapy, or service will produce the same result for everyone.
Mental-health support and physical-condition care have different purposes
Research on hidradenitis suppurativa stigma and emotional health supports taking a person's emotional experience seriously without reducing the physical condition to a mental-health issue. It also supports avoiding the opposite assumption: that emotional distress is irrelevant because the underlying illness is physical. Neither assumption captures the range of experiences described in these studies.
For a broader explanation of available care categories, the guide to mental-health treatment in Massachusetts provides context beyond this condition-specific discussion. Understanding mental-health services is separate from deciding how HS itself should be evaluated or treated. The research summarized here does not establish which service any individual needs.
Merrimack Valley Behavioral Health provides adult outpatient mental-health care. If concealment, stigma, or disrupted participation is part of the emotional strain you want to discuss, you can contact MVBH about available mental-health services. That invitation is separate from HS treatment and does not imply that MVBH provides dermatology care or a specialized HS program.
Reviewed by clinical staff
Frequently Asked Questions
Does everyone with hidradenitis suppurativa feel ashamed or isolated?
No. The qualitative review identified shame, concealment, and disrupted participation within people's accounts, but its themes do not describe every person with HS. The observational study also does not establish a universal experience. Privacy, distress, social connection, and willingness to discuss the condition can differ, so an individual's experience should not be assumed.
What does verbal concealment mean in this research?
Verbal concealment refers to keeping HS out of conversation or not discussing the condition. The qualitative synthesis distinguished this from visual concealment and described anticipation and fear of exposure. It did not establish that everyone who chooses not to discuss HS feels ashamed, nor that disclosure is necessary for coping.
Did the observational study prove that stigma causes depression?
No. It found that higher stigmatization scores correlated with higher depression scores, among other associations. Because the study was cross-sectional, it could not establish the direction of those relationships or demonstrate causation. Its findings also do not mean that an individual with HS has depression or will develop it.
What did participants report about support from other people?
The qualitative synthesis reported that social support and psychological acceptance helped people cope. It also suggested that connecting with others who had HS might help preserve a positive self-identity. These findings describe reported experiences; they do not demonstrate that a particular support group or mental-health service will benefit every person.
Can these studies tell us how common HS stigma is in Massachusetts?
No. The supplied abstracts do not establish Massachusetts-specific prevalence. The qualitative review synthesizes experiences rather than estimating population rates, and the observational study involved 63 adults. Both can inform understanding of reported burdens, but neither supports a claim about how many Massachusetts residents experience stigma, concealment, or related emotional difficulties.